4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-24-002472
Chief Financial Officer sold 2,005 shares at $9.64 ($19,328)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2024-01-29 | Sale | −2,005 | $9.64 | $19,328 | 341,846 | D |
| Open-market sales · 2,005 sh · avg $9.64 · $19,328 | |||||||
Loading xslF345X05/doc4.xml…